Microbiome modulation as a novel therapeutic approach in chr... : Current Opinion in
Nephrology and Hypertension Microbiome modulation as a novel therapeutic approach in …

There is increasing interest in the therapeutic potential of manipulating the gut microbiome
of patients with chronic kidney disease (CKD). This is because there is a substantial …

Chronic kidney disease (CKD) is a worldwide public health issue and has ultimately
progressed to an end-stage renal disease that requires life-long dialysis or renal …

Recent advances in microbiome research have informed the potential role of the gut
microbiota in the regulation of metabolic, cardiovascular, and renal systems, and, when …

In chronic kidney disease (CKD), the progressive decline in the renal excretory function
leads to accumulation of urea and toxins in the blood. The CKD-associated dysbiosis of gut …

Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …

Emerging evidence suggests that gastrointestinal (GI) microbiota dysbiosis is associated
with chronic kidney disease (CKD) and metabolite concentrations. The purpose of this …

The complicated communities of microbiota colonizing the human gastrointestinal tract exert
a strong function in health maintenance and disease prevention. Indeed, accumulating …

Gut microbiota imbalance is common in patients with chronic kidney disease (CKD) and
associates with factors such as increased circulating levels of gut-derived uremic toxins …

There is increasing clinical evidence that patients with chronic kidney disease (CKD) have a
distinctly dysbiotic intestinal bacterial community, termed the gut microbiota, which in turn …